People with diabetes (PWD) are included in the group at increased risk of severe illness from coronavirus (COVID-19) and have been advised to observe stringent social distancing measures.(1) This creates a difficult situation for PWD and their Health Care Providers (HCP) as PWD require an annual review including retinal screening as part of their screening for complications, which involves a physical visit to a community or hospital facility or an eye clinic.
This rapid review addresses the following questions:
- How can we help stratify annual retinal screening programmes for PWD during the COVID-19 pandemic?
- Can we do remote retinal review for PWD?
- What can we do to control the risk factors for development or progression of diabetic retinopathy during the COVID-19 pandemic?
- Is hydroxycholoroquine safe to use in individuals with diabetic retinopathy?
Ahmad, E., Davies, M.J. and Khunti, K., Rapid Review: Diabetic retinopathy screening during the COVID-19 pandemic.
Access the publication here: https://www.cebm.net/covid-19/rapid-review-diabetic-retinopathy-screening-during-the-covid-19-pandemic/